Immunotherapy Today

Immunotherapy News From Around The World

< Immunotherapy Today home

Author: btwatson

  • CD19 in Brain Cells May Be Cause of Immunotherapy-Related Neurotoxicity – Technology Networks
    CD19 in Brain Cells May Be Cause of Immunotherapy-Related Neurotoxicity – Technology Networks
  • Immunotherapy Drug Boosts Survival With Bladder Cancer | Health News – U.S. News & World Report
  • Tiniest Cancer Immunotherapy Trial Participant Thrives Six Years Later – On the Pulse
    Tiniest Cancer Immunotherapy Trial Participant Thrives Six Years Later – On the Pulse
  • Biotheranostics CancerTYPE ID aids in patient selection for immunotherapy – GlobeNewswire
  • Keytruda rules the immunotherapy market, but challengers are lining up – STAT
    Keytruda rules the immunotherapy market, but challengers are lining up – STAT
  • Immunotherapy is beneficial in gastric and oesophageal cancers, studies show – EurekAlert
    Immunotherapy is beneficial in gastric and oesophageal cancers, studies show – EurekAlert
  • Increasing the effectiveness of cancer treatments: Anti-PD-L1 immunotherapy – Medical Xpress
    Increasing the effectiveness of cancer treatments: Anti-PD-L1 immunotherapy – Medical Xpress
  • Merck matches Roche in search for next cancer immunotherapy – BioPharma Dive
    Merck matches Roche in search for next cancer immunotherapy – BioPharma Dive
  • Penn researchers discover potential cause of immunotherapy-related neurotoxicity – EurekAlert
    Penn researchers discover potential cause of immunotherapy-related neurotoxicity – EurekAlert
  • Biotheranostics CancerTYPE ID aids in patient selection for immunotherapy – GlobeNewswire
< Newer Entries   |   Older Entries >
Copyright 2018 ImmunoTherapyToday.com